Beta Bionics, Inc. (BBNX)
10.18
+0.28
(+2.78%)
USD |
NASDAQ |
Apr 30, 16:00
10.18
0.00 (0.00%)
After-Hours: 20:00
Beta Bionics EPS Diluted (Quarterly) : -0.4927 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 0.6165 |
| Insulet Corp. | 1.441 |
| Tandem Diabetes Care, Inc. | -0.0087 |
| Accuray, Inc. | -0.1138 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.90M |
| Revenue (Quarterly) | 27.63M |
| Total Expenses (Quarterly) | 49.52M |
| Enterprise Value | 248.45M |
| Gross Profit Margin (Quarterly) | 59.50% |
| Profit Margin (Quarterly) | -79.26% |
| Earnings Yield | -14.85% |
| Normalized Earnings Yield | -14.85 |